Here you will find information on PAION AG i.L. relevant to stock corporation and stock exchange law.
PAION Pharma GmbH as part of the insolvency proceedings.
PAION Pharma GmbH at www.paionpharma.com
General Information on CeNeS Acquisition
In 2008 PAION acquired the company CeNeS Pharmaceuticals plc based in Cambridge, Great Britain. The drugs Remimazolam, M6G und Solulin derive from this transaction.
News:
Ad hoc release: PAION AG completes acquisition of CeNeS
23 June 2008
press release: PAION AG completes acquisition of CeNeS
23 June 2008
Press release: Court sanctions Scheme of Arrangement for acquisition of CeNeS
20 June 2008
Regulatory release: AIM Prospective Admission
11 June 2008
Press release: Shareholders of CeNeS vote for acquisition by PAION
28 May 2008
Press release: PAION Annual General Meeting and CeNeS Acquisition Update
6 May 2008
Ad-hoc PAION AG intends to acquire CeNeS Pharmaceuticals plc
10 April 2008
press PAION AG intends to acquire CeNeS Pharmaceuticals plc
10 April 2008
Documents:
Scheme Document
7. Mai 2008
2.5 Announcement
10. April 2008
Prospectus:
PAION Prospectus for the Public Offer and Admission to Trading of up to 7,850,000 ordinary no-par value bearer shares
16.05.2008
